Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

Managing Daily Life: A Team Approach to NIID Care

At a Glance

NIID has no current disease-modifying cure, so care focuses on treating symptoms and preventing complications. Neurologists and other specialists may support movement, bladder and blood pressure problems, cognition, seizures, swallowing, nutrition, safety, and independence.

Managing Neuronal Intranuclear Inclusion Disease (NIID) requires a multidisciplinary approach, meaning a team of different specialists works together to address the wide variety of symptoms that can occur [1].

Because there is currently no disease-modifying cure that stops the underlying genetic process, care focuses on supportive management: treating the symptoms you have, preventing complications, and maximizing your comfort and independence [2][1].

Managing Movement and Physical Symptoms

Movement issues in NIID, such as tremors or stiffness (parkinsonism), are often treated similarly to Parkinson’s disease, but the results can vary [3].

  • Levodopa Trials: Doctors may recommend a trial of levodopa (a standard Parkinson’s medication). While some patients see improvement in their movement, others find the benefit is only temporary or limited by side effects like nausea, vomiting, orthostatic hypotension, or dyskinesia [1][4].
  • Rehabilitation: Physical and Occupational Therapy are essential for maintaining mobility. Therapists focus on balance training, gait safety, and recommending assistive devices (like canes or walkers) to prevent falls, which are a significant risk in NIID [1][5].
  • Weakness and Neuropathy: Since many patients have peripheral neuropathy (nerve damage), regular foot checks and comfortable, supportive footwear are important to prevent injury [6].

Addressing Autonomic and Internal Symptoms

The autonomic nervous system—which controls “automatic” functions like digestion and blood pressure—is affected in over 90% of people with NIID [7].

  • Bladder Care: Bladder dysfunction is extremely common. Management may include medications to reduce urgency or, in some cases, the use of a catheter if the bladder is not emptying fully. These treatments require careful review of heart, kidney, blood-pressure, and infection risks [8][9].
  • Digestive Support: Symptoms like chronic constipation or sudden bouts of vomiting require a tailored plan. For severe, drug-refractory vomiting, some patients have seen improvement with corticosteroid therapy; however, this is not a routine disease-modifying treatment and is considered by specialists only after excluding infections and weighing serious risks like high blood sugar and cognitive effects [10][11].
  • Blood Pressure: Orthostatic hypotension (a drop in blood pressure when standing) can cause dizziness or fainting. Management often includes staying well-hydrated, wearing compression stockings, and carefully reviewing any medications that might lower blood pressure further, though these interventions require review of heart, kidney, and infection risks [12][10].

Cognitive, Seizure, and Safety Monitoring

As the disease progresses, cognitive changes and sudden neurological “episodes” need proactive management.

  • Cognitive Support: While medications like donepezil are sometimes used for memory, their effectiveness in NIID is not yet proven [5]. Care focuses on environmental safety, cognitive exercises, and treating secondary issues like anxiety or depression [13].
  • Seizure Management: Sudden episodes of confusion or “stroke-like” events may actually be seizures [14]. If an EEG (a test of brain waves) shows seizure activity, doctors will prescribe anti-seizure medications (ASMs) to help stabilize brain activity [15].
  • Swallowing and Nutrition: NIID can cause dysphagia (difficulty swallowing), which increases the risk of aspiration (food or liquid entering the lungs) [16]. A speech-language pathologist can perform a swallowing study to recommend safe food textures and techniques [16].

The Importance of a Care Team

Because NIID is complex, your team should ideally include a neurologist, urologist, gastroenterologist, and physical therapist [1]. Early involvement of a palliative care specialist can also be helpful—not just for end-of-life care, but to help manage complex symptoms and improve your daily quality of life at any stage of the journey [1].

Common questions in this guide

Is there a treatment that stops NIID from progressing?
There is currently no disease-modifying cure that stops the underlying genetic process in NIID. Treatment is supportive, meaning it focuses on relieving symptoms, preventing complications, and preserving comfort and independence.
What can help movement problems in NIID?
Doctors may offer a trial of levodopa, a medicine commonly used for Parkinson’s disease, but the benefit can be limited or temporary. Physical and occupational therapy, balance and walking training, and appropriate canes or walkers can help maintain mobility and reduce falls; levodopa can also cause side effects such as nausea, vomiting, low blood pressure when standing, or involuntary movements.
How are bladder and blood pressure symptoms treated in NIID?
Bladder urgency may be treated with medication, while incomplete emptying may require a catheter. Dizziness or fainting from a blood-pressure drop on standing may be addressed with hydration, compression stockings, and a review of medicines, while clinicians consider other health risks.
How can doctors check whether the bladder is emptying fully?
A clinician can measure the post-void residual, which is the amount of urine left in the bladder after urinating. The result and your symptoms can guide decisions about medication, catheter use, and further monitoring.
What should I do if NIID makes swallowing difficult?
Difficulty swallowing can let food or liquid enter the lungs, a problem called aspiration. A speech-language pathologist can perform a swallowing assessment and recommend safer food textures, drinking methods, and eating techniques.
Could sudden confusion or a stroke-like episode be a seizure in NIID?
Yes, sudden confusion or stroke-like episodes can sometimes be caused by seizures rather than a stroke. If an EEG, which records brain-wave activity, shows seizure activity, a clinician may prescribe anti-seizure medicine to help stabilize brain activity.
Which specialists are usually involved in NIID care?
Care may include a neurologist, urologist, gastroenterologist, physical therapist, occupational therapist, and speech-language pathologist, depending on the symptoms. Palliative care can also help manage difficult symptoms and support quality of life at any stage, not only near the end of life.

Get notified when new evidence is published on Neuronal intranuclear inclusion disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report.

    Zang P, Liu Y, Hao Y

    BMC neurology 2026; (26(1)).

    PMID: 41634634
  2. 2

    Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report.

    Sun L, Zhou L, Ren L, et al.

    Medicine 2024; (103(47)):e40636 doi:10.1097/MD.0000000000040636.

    PMID: 39809216
  3. 3

    Neuronal intranuclear inclusion disease misdiagnosed as Parkinson's disease: a case report.

    Yu D, Li J, Tai H, et al.

    The Journal of international medical research 2024; (52(3)):3000605241233159 doi:10.1177/03000605241233159.

    PMID: 38436278
  4. 4

    Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

    Vermilion J, Johnson M, Srinivasan J, Mink JW

    Journal of child neurology 2019; (34(13)):801-805 doi:10.1177/0883073819860566.

    PMID: 31304825
  5. 5

    [Adult-Onset Neuronal Intranuclear Inclusion Disease in Two Female Siblings].

    Yoshimoto T, Takamatsu K, Kurashige T, et al.

    Brain and nerve = Shinkei kenkyu no shinpo 2017; (69(3)):267-274 doi:10.11477/mf.1416200737.

    PMID: 28270636
  6. 6

    Diagnostic value of nerve conduction study in NOTCH2NLC-related neuronal intranuclear inclusion disease.

    Tian Y, Hou X, Cao W, et al.

    Journal of the peripheral nervous system : JPNS 2023; (28(4)):629-641 doi:10.1111/jns.12599.

    PMID: 37749855
  7. 7

    Characteristics of autonomic dysfunction in neuronal intranuclear inclusion disease.

    Zhou L, Tian Y, Zhang S, et al.

    Frontiers in neurology 2023; (14()):1168904 doi:10.3389/fneur.2023.1168904.

    PMID: 37388545
  8. 8

    Urodynamic Assessment of Neuronal Intranuclear Inclusion Disease.

    Aiba Y, Sakakibara R, Lee FC, Tateno F

    European neurology 2020; (83(3)):312-316 doi:10.1159/000508746.

    PMID: 32645705
  9. 9

    Adult-Onset Neuronal Intranuclear Inclusion Disease Initially Manifesting as Bladder Dysfunction: A Case Report.

    Yamaki A, Sekino H, Kawana S, et al.

    Cureus 2026; (18(3)):e105488 doi:10.7759/cureus.105488.

    PMID: 42005169
  10. 10

    Rapidly progressive adult-onset neuronal intranuclear inclusion disease beginning with autonomic symptoms: a case report.

    Zhu Y, Yang Q, Tian Y, et al.

    Frontiers in neurology 2023; (14()):1190981 doi:10.3389/fneur.2023.1190981.

    PMID: 37305750
  11. 11

    Adult-onset neuronal intranuclear inclusion disease initially presenting with prominent gastrointestinal symptoms: a case report.

    Yuan X, Yang Y, Tang Y, Luo Q

    BMC neurology 2026; (26(1)).

    PMID: 41845318
  12. 12

    Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease.

    Miyaue N, Ochi C, Ito YH, et al.

    Internal medicine (Tokyo, Japan) 2024; (63(8)):1163-1166 doi:10.2169/internalmedicine.2384-23.

    PMID: 38616117
  13. 13

    Psychiatric-onset neuronal intranuclear inclusion disease in a psychiatry-based dementia-enriched cohort in Japan.

    Miyamoto T, Mori K, Akamine S, et al.

    Psychiatry and clinical neurosciences 2025; (79(9)):561-571 doi:10.1111/pcn.13854.

    PMID: 40515658
  14. 14

    Clinical features of neuronal intranuclear inclusion disease with seizures: a systematic literature review.

    Zhang J, Ling L, Xiang L, et al.

    Frontiers in neurology 2024; (15()):1387399 doi:10.3389/fneur.2024.1387399.

    PMID: 38707999
  15. 15

    Case Report: Distinctive features of cognitive dysfunction and amelioration by antiseizure medication in neuronal intranuclear inclusion disease.

    Ohara H, Yamanaka M, Okada F, et al.

    Frontiers in neuroscience 2026; (20()):1734078 doi:10.3389/fnins.2026.1734078.

    PMID: 41716662
  16. 16

    Neuronal intranuclear inclusion disease presenting with dysphagia: a report of three cases.

    Aoyagi Y, Taya M, Ohashi M, Saitoh E

    Neurocase 2020; (26(4)):252-257 doi:10.1080/13554794.2020.1788607.

    PMID: 32619141

This page is for informational purposes only and does not constitute medical advice. Your neurologist and care team can tailor NIID treatments, monitoring, and safety plans to your symptoms.